Abilify MyCite

Product NDC: 59148-030
11-digit product format: 591480030
Labeler code: 59148
Product ID: 59148-030_3cbd66b3-7c90-44fc-9c44-3f290e6144e6
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ARIPIPRAZOLE
Dosage form: TABLET WITH SENSOR
Route: ORAL
Labeler: Otsuka America Pharmaceutical, Inc.
Application: NDA207202
Marketing category: NDA
Marketing start: 2018-01-31
Marketing end: 0000-00-00
Substance: ARIPIPRAZOLE
Active strength: 5 mg/1
Pharmacologic classes: Atypical Antipsychotic [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	59148-030		D	Discontinued by firm	2026-09-14
excluded package	package	59148-030	59148-030-61	D	Discontinued by firm	2026-09-14
excluded package	package	59148-030	59148-030-72	D	Discontinued by firm	2026-09-14

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 6 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N207202-001	ABILIFY MYCITE KIT	ARIPIPRAZOLE	2MG	TABLET / ORAL	RLD	2017-11-13
N207202-002	ABILIFY MYCITE KIT	ARIPIPRAZOLE	5MG	TABLET / ORAL	RLD	2017-11-13
N207202-003	ABILIFY MYCITE KIT	ARIPIPRAZOLE	10MG	TABLET / ORAL	RLD	2017-11-13
N207202-004	ABILIFY MYCITE KIT	ARIPIPRAZOLE	15MG	TABLET / ORAL	RLD	2017-11-13
N207202-005	ABILIFY MYCITE KIT	ARIPIPRAZOLE	20MG	TABLET / ORAL	RLD	2017-11-13
N207202-006	ABILIFY MYCITE KIT	ARIPIPRAZOLE	30MG	TABLET / ORAL	RLD	2017-11-13

Orange Book patents#

Current patent rows page 1 of 3 · 162 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N207202-001	11476952	2026-04-28		Drug product	2022-11-09
N207202-001	9125939	2026-07-28	U-1749		2017-12-12
N207202-001	7978064	2026-09-14		Drug product	2017-12-12
N207202-001	8759350	2027-03-02	U-1529		2017-12-12
N207202-001	9444503	2027-11-19	U-2169	Drug product	2017-12-12
N207202-001	9119554	2028-12-16		Drug product	2017-12-12
N207202-001	9060708	2029-03-05		Drug product	2017-12-12
N207202-001	9258035	2029-03-05		Drug product	2017-12-12
N207202-001	8674825	2029-04-09	U-2170	Drug product	2017-12-12
N207202-001	8956288	2029-07-06	U-2167	Drug product	2017-12-12
N207202-001	10441194	2029-07-26		Drug product	2019-11-01
N207202-001	8945005	2029-08-19	U-2167	Drug product	2017-12-12
N207202-001	9433371	2029-09-15		Drug product	2017-12-12
N207202-001	8718193	2029-12-05		Drug product	2017-12-12
N207202-001	9149577	2029-12-15		Drug product	2017-12-12
N207202-001	8847766	2030-03-29	U-2167	Drug product	2017-12-12
N207202-001	8545402	2030-04-27		Drug product	2017-12-12
N207202-001	8114021	2030-06-21		Drug product	2017-12-12
N207202-001	11464423	2030-09-15		Drug product	2022-11-09
N207202-001	9941931	2030-11-04		Drug product	2018-05-07
N207202-001	8961412	2030-11-17		Drug product	2017-12-12
N207202-001	8258962	2030-11-25		Drug product	2017-12-12
N207202-001	8547248	2030-12-18	U-2167	Drug product	2017-12-12
N207202-001	11229378	2031-07-11		Drug product	2022-02-18
N207202-001	9320455	2031-12-15		Drug product	2017-12-12
N207202-001	10517507	2032-06-13		Drug product	2020-01-23
N207202-001	9268909	2033-10-15	U-2168	Drug product	2017-12-12
N207202-002	11476952	2026-04-28		Drug product	2022-11-09
N207202-002	9125939	2026-07-28	U-1749		2017-12-12
N207202-002	7978064	2026-09-14		Drug product	2017-12-12
N207202-002	8759350	2027-03-02	U-1529		2017-12-12
N207202-002	9444503	2027-11-19	U-2169	Drug product	2017-12-12
N207202-002	9119554	2028-12-16		Drug product	2017-12-12
N207202-002	9060708	2029-03-05		Drug product	2017-12-12
N207202-002	9258035	2029-03-05		Drug product	2017-12-12
N207202-002	8674825	2029-04-09	U-2170	Drug product	2017-12-12
N207202-002	8956288	2029-07-06	U-2167	Drug product	2017-12-12
N207202-002	10441194	2029-07-26		Drug product	2019-11-01
N207202-002	8945005	2029-08-19	U-2167	Drug product	2017-12-12
N207202-002	9433371	2029-09-15		Drug product	2017-12-12
N207202-002	8718193	2029-12-05		Drug product	2017-12-12
N207202-002	9149577	2029-12-15		Drug product	2017-12-12
N207202-002	8847766	2030-03-29	U-2167	Drug product	2017-12-12
N207202-002	8545402	2030-04-27		Drug product	2017-12-12
N207202-002	8114021	2030-06-21		Drug product	2017-12-12
N207202-002	11464423	2030-09-15		Drug product	2022-11-09
N207202-002	9941931	2030-11-04		Drug product	2018-05-07
N207202-002	8961412	2030-11-17		Drug product	2017-12-12
N207202-002	8258962	2030-11-25		Drug product	2017-12-12
N207202-002	8547248	2030-12-18	U-2167	Drug product	2017-12-12
N207202-002	11229378	2031-07-11		Drug product	2022-02-18
N207202-002	9320455	2031-12-15		Drug product	2017-12-12
N207202-002	10517507	2032-06-13		Drug product	2020-01-23
N207202-002	9268909	2033-10-15	U-2168	Drug product	2017-12-12
N207202-003	11476952	2026-04-28		Drug product	2022-11-09
N207202-003	9125939	2026-07-28	U-1749		2017-12-12
N207202-003	7978064	2026-09-14		Drug product	2017-12-12
N207202-003	8759350	2027-03-02	U-1529		2017-12-12
N207202-003	9444503	2027-11-19	U-2169	Drug product	2017-12-12
N207202-003	9119554	2028-12-16		Drug product	2017-12-12
N207202-003	9060708	2029-03-05		Drug product	2017-12-12
N207202-003	9258035	2029-03-05		Drug product	2017-12-12
N207202-003	8674825	2029-04-09	U-2170	Drug product	2017-12-12
N207202-003	8956288	2029-07-06	U-2167	Drug product	2017-12-12
N207202-003	10441194	2029-07-26		Drug product	2019-11-01
N207202-003	8945005	2029-08-19	U-2167	Drug product	2017-12-12
N207202-003	9433371	2029-09-15		Drug product	2017-12-12
N207202-003	8718193	2029-12-05		Drug product	2017-12-12
N207202-003	9149577	2029-12-15		Drug product	2017-12-12
N207202-003	8847766	2030-03-29	U-2167	Drug product	2017-12-12
N207202-003	8545402	2030-04-27		Drug product	2017-12-12
N207202-003	8114021	2030-06-21		Drug product	2017-12-12
N207202-003	11464423	2030-09-15		Drug product	2022-11-09
N207202-003	9941931	2030-11-04		Drug product	2018-05-07
N207202-003	8961412	2030-11-17		Drug product	2017-12-12
N207202-003	8258962	2030-11-25		Drug product	2017-12-12
N207202-003	8547248	2030-12-18	U-2167	Drug product	2017-12-12
N207202-003	11229378	2031-07-11		Drug product	2022-02-18
N207202-003	9320455	2031-12-15		Drug product	2017-12-12
N207202-003	10517507	2032-06-13		Drug product	2020-01-23

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-005	ABILIFY MYCITE KIT	20MG	TABLET / ORAL	RLD	2017-11-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-006	ABILIFY MYCITE KIT	30MG	TABLET / ORAL	RLD	2017-11-13	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N207202-005	ABILIFY MYCITE KIT	20MG	TABLET / ORAL	RLD	2017-11-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N207202-006	ABILIFY MYCITE KIT	30MG	TABLET / ORAL	RLD	2017-11-13	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207202-005	ABILIFY MYCITE KIT	20MG	TABLET / ORAL	RLD	2017-11-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207202-006	ABILIFY MYCITE KIT	30MG	TABLET / ORAL	RLD	2017-11-13	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207202-005	ABILIFY MYCITE KIT	20MG	TABLET / ORAL	RLD	2017-11-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207202-006	ABILIFY MYCITE KIT	30MG	TABLET / ORAL	RLD	2017-11-13	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207202-005	ABILIFY MYCITE KIT	20MG	TABLET / ORAL	RLD	2017-11-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207202-006	ABILIFY MYCITE KIT	30MG	TABLET / ORAL	RLD	2017-11-13	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207202-005	ABILIFY MYCITE KIT	20MG	TABLET / ORAL	RLD	2017-11-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207202-006	ABILIFY MYCITE KIT	30MG	TABLET / ORAL	RLD	2017-11-13	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`b8a1b40f171c…`

Observed Orange Book patent history#

Patent history page 1 of 197 · 7,854 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N207202-001	11476952	2026-04-28		Drug product	2022-11-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9125939	2026-07-28	U-1749		2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	7978064	2026-09-14		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8759350	2027-03-02	U-1529		2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9444503	2027-11-19	U-2169	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9119554	2028-12-16		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9060708	2029-03-05		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9258035	2029-03-05		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8674825	2029-04-09	U-2170	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8956288	2029-07-06	U-2167	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	10441194	2029-07-26		Drug product	2019-11-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8945005	2029-08-19	U-2167	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9433371	2029-09-15		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8718193	2029-12-05		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9149577	2029-12-15		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8847766	2030-03-29	U-2167	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8545402	2030-04-27		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8114021	2030-06-21		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	11464423	2030-09-15		Drug product	2022-11-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9941931	2030-11-04		Drug product	2018-05-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8961412	2030-11-17		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8258962	2030-11-25		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8547248	2030-12-18	U-2167	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	11229378	2031-07-11		Drug product	2022-02-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9320455	2031-12-15		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	10517507	2032-06-13		Drug product	2020-01-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9268909	2033-10-15	U-2168	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	11476952	2026-04-28		Drug product	2022-11-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	9125939	2026-07-28	U-1749		2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	7978064	2026-09-14		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	8759350	2027-03-02	U-1529		2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	9444503	2027-11-19	U-2169	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	9119554	2028-12-16		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	9060708	2029-03-05		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	9258035	2029-03-05		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	8674825	2029-04-09	U-2170	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	8956288	2029-07-06	U-2167	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	10441194	2029-07-26		Drug product	2019-11-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	8945005	2029-08-19	U-2167	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	9433371	2029-09-15		Drug product	2017-12-12	`84e616aacf4f…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N207202-001	I-746	2020-07-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N207202-002	I-746	2020-07-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N207202-003	I-746	2020-07-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N207202-004	I-746	2020-07-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N207202-005	I-746	2020-07-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N207202-006	I-746	2020-07-27	`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	N207202-001	I-746	2020-07-27	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N207202-002	I-746	2020-07-27	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N207202-003	I-746	2020-07-27	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N207202-004	I-746	2020-07-27	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N207202-005	I-746	2020-07-27	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N207202-006	I-746	2020-07-27	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N207202-001	I-746	2020-07-27	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N207202-002	I-746	2020-07-27	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N207202-003	I-746	2020-07-27	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N207202-004	I-746	2020-07-27	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N207202-005	I-746	2020-07-27	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N207202-006	I-746	2020-07-27	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N207202-001	I-746	2020-07-27	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N207202-002	I-746	2020-07-27	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N207202-003	I-746	2020-07-27	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N207202-004	I-746	2020-07-27	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N207202-005	I-746	2020-07-27	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N207202-006	I-746	2020-07-27	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N207202-001	I-746	2020-07-27	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N207202-002	I-746	2020-07-27	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N207202-003	I-746	2020-07-27	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N207202-004	I-746	2020-07-27	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N207202-005	I-746	2020-07-27	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N207202-006	I-746	2020-07-27	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N207202-001	I-746	2020-07-27	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N207202-002	I-746	2020-07-27	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N207202-003	I-746	2020-07-27	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N207202-004	I-746	2020-07-27	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N207202-005	I-746	2020-07-27	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N207202-006	I-746	2020-07-27	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
59148-030-61	2021-08-02	These highlights do not include all the information needed to use ABILIFY MYCITE safely and effectively. See full prescribing information for ABILIFY MYCITE. ABILIFY MYCITE ® (aripiprazole tablets with sensor), for oral use Initial U.S. Approval: 2002
59148-030-72	2021-08-02	These highlights do not include all the information needed to use ABILIFY MYCITE safely and effectively. See full prescribing information for ABILIFY MYCITE. ABILIFY MYCITE ® (aripiprazole tablets with sensor), for oral use Initial U.S. Approval: 2002
59148-030-85	2021-08-02	These highlights do not include all the information needed to use ABILIFY MYCITE safely and effectively. See full prescribing information for ABILIFY MYCITE. ABILIFY MYCITE ® (aripiprazole tablets with sensor), for oral use Initial U.S. Approval: 2002
59148-030-90	2021-08-02	These highlights do not include all the information needed to use ABILIFY MYCITE safely and effectively. See full prescribing information for ABILIFY MYCITE. ABILIFY MYCITE ® (aripiprazole tablets with sensor), for oral use Initial U.S. Approval: 2002
59148-030-61	2021-07-23	These highlights do not include all the information needed to use ABILIFY MYCITE safely and effectively. See full prescribing information for ABILIFY MYCITE. ABILIFY MYCITE ® (aripiprazole tablets with sensor), for oral use Initial U.S. Approval: 2002
59148-030-72	2021-07-23	These highlights do not include all the information needed to use ABILIFY MYCITE safely and effectively. See full prescribing information for ABILIFY MYCITE. ABILIFY MYCITE ® (aripiprazole tablets with sensor), for oral use Initial U.S. Approval: 2002
59148-030-85	2021-07-23	These highlights do not include all the information needed to use ABILIFY MYCITE safely and effectively. See full prescribing information for ABILIFY MYCITE. ABILIFY MYCITE ® (aripiprazole tablets with sensor), for oral use Initial U.S. Approval: 2002
59148-030-90	2021-07-23	These highlights do not include all the information needed to use ABILIFY MYCITE safely and effectively. See full prescribing information for ABILIFY MYCITE. ABILIFY MYCITE ® (aripiprazole tablets with sensor), for oral use Initial U.S. Approval: 2002

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59148-030-61	EA - Each	59148-030	4665423a-220e-420d-8870-56a50e8ac0ce	1	2021-06-02
59148-030-72	EA - Each	59148-030	76602dd7-9a3b-4ae2-8fa5-eee58df2ae21	1	2021-06-02
59148-030-85	EA - Each	59148-030	fa40e467-c8a8-4d7e-8476-1fd2d2a85f80	1	2018-12-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59148-030	ABILIFY MYCITE (ARIPIPRAZOLE) TABLET WITH SENSOR [OTSUKA AMERICA PHARMACEUTICAL, INC.]	16	Legacy NDC	20250202_e8787c3f-5e41-42d1-8091-44b56346620f.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
82VFR53I78	ARIPIPRAZOLE	129722-12-9	ARIPIPRAZOLE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
59148-030-61	59148003061	1 BOTTLE in 1 KIT (59148-030-61) > 30 TABLET WITH SENSOR in 1 BOTTLE (59148-030-13)	1 bottle	2020-12-19	0000-00-00	No	No	Current
59148-030-72	59148003072	1 BOTTLE in 1 KIT (59148-030-72) > 30 TABLET WITH SENSOR in 1 BOTTLE (59148-030-13)	1 bottle	2020-12-19	0000-00-00	No	No	Current
59148-030-85	59148003085	1 BOTTLE in 1 KIT (59148-030-85) > 30 TABLET WITH SENSOR in 1 BOTTLE (59148-030-13)	1 bottle	2018-01-31	0000-00-00	No	No	Current
59148-030-90	59148003090	1 BOTTLE in 1 KIT (59148-030-90) > 7 TABLET WITH SENSOR in 1 BOTTLE (59148-030-07)	1 bottle	2018-01-31	0000-00-00	No	No	Current